-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
Oramed Pharmaceuticals Inc. quarterly/annual Depreciation history and growth rate from Q4 2010 to Q1 2024.
- Oramed Pharmaceuticals Inc. Depreciation for the quarter ending March 31, 2024 was $56K, a 51.4% increase year-over-year.
- Oramed Pharmaceuticals Inc. annual Depreciation for 2023 was $196K, a 238% increase from 2022.
- Oramed Pharmaceuticals Inc. annual Depreciation for 2022 was $58K, a 24.7% decline from 2021.
- Oramed Pharmaceuticals Inc. annual Depreciation for 2021 was $77K, a 1000% increase from 2020.
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)